Related Experiment Video
Updated: Aug 20, 2026

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
Published on: September 13, 2024
ERK-MAP-kinases differentially regulate expression of IL-23 p19 compared with p40 and IFN-beta in Theiler's
1Department of Oral Biology, the Nebraska Center for Virology, University of Nebraska Medical Center, Lincoln, NE 68583, USA. tpetro@unmc.edu
Abstract:
Theiler's murine encephalomyelitis virus (TMEV) infection of macrophages induces a demyelinating disease (DD) in certain strains of mice that is similar to human multiple sclerosis. In contrast to IFN-beta, expression of IL-23 p19 and p40 subunits by macrophages in response to TMEV may contribute to DD. TMEV infection of macrophages likely induces IL-23 and IFN-beta by activating p38 or ERK MAP-kinases (MAPK) and the p38 substrate ATF-2 within 30 min. To determine the role of MAPKs in TMEV-induced IL-23 and IFN-beta expression, RAW264.7 cells were pretreated with SB203580 or U0126, inhibitors of p38 and ERK MAPKs, respectively. SB203580 significantly increased TMEV-induced p19 but decreased p40 expression. In contrast, U0126 decreased p19 and increased TMEV-induced p40 and IFN-beta expression. Interestingly, U0126 prolonged TMEV-induced ATF-2 activation to at least 3h. Thus ERK MAPKs regulate expression of TMEV-induced p19 differently than p40 and IFN-beta suggesting the benefits of U0126 in treatment of DD.
Insights
Theiler
Area of Science:
- Neuroimmunology
- Virology
- Cellular Biology
Background:
- Theiler's murine encephalomyelitis virus (TMEV) infection in mice causes a demyelinating disease (DD) analogous to human multiple sclerosis.
- Interleukin-23 (IL-23) subunits (p19 and p40) and Interferon-beta (IFN-beta) expression by macrophages following TMEV infection may contribute to DD pathogenesis.
- Mitogen-activated protein kinases (MAPKs), including p38 and Extracellular signal-regulated kinases (ERK), are implicated in TMEV-induced cytokine expression.
Purpose of the Study:
- To investigate the specific roles of p38 and ERK MAPKs in regulating TMEV-induced IL-23 and IFN-beta expression in macrophages.
- To elucidate the differential regulation of IL-23 p19, p40 subunits, and IFN-beta by distinct MAPK pathways during TMEV infection.
Main Methods:
- RAW264.7 macrophage cell line was utilized for in vitro studies.
- Cells were pretreated with specific MAPK inhibitors: SB203580 (p38 inhibitor) and U0126 (ERK inhibitor).
- Expression levels of IL-23 p19, p40, and IFN-beta were quantified post-TMEV infection.
- Activation of the p38 substrate ATF-2 was monitored over time.
Main Results:
- SB203580 (p38 inhibitor) increased IL-23 p19 expression but decreased p40 expression.
- U0126 (ERK inhibitor) decreased IL-23 p19 expression while increasing p40 and IFN-beta expression.
- U0126 treatment prolonged the activation of ATF-2 induced by TMEV infection.
Conclusions:
- ERK MAPKs differentially regulate the expression of TMEV-induced IL-23 p19 compared to p40 and IFN-beta.
- The distinct effects of ERK inhibition on cytokine expression suggest potential therapeutic strategies for TMEV-induced demyelinating disease.
Related Concept Videos
MAPK Signaling Cascades
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

